# Role of Bilirubin Molecular Species in Hepatic Encephalopathy and Acute-on-chronic Liver Failure

> **NCT05566548** · — · UNKNOWN · sponsor: **Medica Sur Clinic & Foundation** · enrollment: 50 (estimated)

## Conditions studied

- Hepatic Encephalopathy
- Acute-On-Chronic Liver Failure

## Interventions

- **DIAGNOSTIC_TEST:** Liquid Chromatography-Mass Spectrometry Method to identify bilirubin molecular species

## Key facts

- **NCT ID:** NCT05566548
- **Lead sponsor:** Medica Sur Clinic & Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05566548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05566548, "Role of Bilirubin Molecular Species in Hepatic Encephalopathy and Acute-on-chronic Liver Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05566548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*